Content about Clinical research

April 26, 2012
FDA declines to approve Takeda diabetes drug

The Food and Drug Administration declined to approve a drug made by Takeda Pharmaceutical, the drug maker said.

April 25, 2012
Amgen to buy Turkish drug maker for $700 million

Biotech drug maker Amgen is buying a pharmaceutical company based in Turkey, the companies said Wednesday.

April 24, 2012
FDA outlines global food, drug, device safety strategy

Globalization has led to a rapid increase in the drugs and foods arriving on U.S. shores from abroad, a trend that has prompted U.S. regulators to transform their approach.

April 20, 2012
Generics among fastest-growing industries this decade, report finds

According to the latest numbers, the country's economy is slowly growing, while unemployment has been slowly declining. But while growth has been somewhat less than stellar, 10 industries have outpaced the rest of the economy, including generic drugs.

April 19, 2012
GPhA signs on with IMS Health to address drug shortages

A trade organization representing generic drug manufacturers announced Thursday its latest solution to the problem of drug shortages.

April 16, 2012
Merck, Endocyte sign deal to develop cancer drug

Two drug makers have signed a deal to develop an experimental drug for treating two types of cancer.

April 13, 2012
Drug makers invested $49.5 billion in R&D in 2011, report finds

Drug companies invested nearly $50 billion in research and development in 2011, according to a new report by a drug industry trade group.

April 10, 2012
Amgen to acquire Kai for $315 million

Biotech manufacturer Amgen will acquire the private South San Francisco, Calif.-based drug developer Kai Pharmaceuticals for $315 million, the companies said Tuesday.

April 10, 2012
FDA approves Watson diarrhea drug

The Food and Drug Administration has approved a generic version of a drug for diarrhea made by Watson, the company said Tuesday.

March 30, 2012
Genentech announces results of cancer drug trial

Breast cancer patients taking an experimental drug made by Roche subsidiary Genentech lived significantly longer than those taking another drug made by GlaxoSmithKline, according to results of a late-stage clinical trial.

March 27, 2012
FDA approves J&J HIV drug in children

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating HIV in children.

March 21, 2012
FDA advisory committee votes in favor of GSK's Votrient

A Food and Drug Administration expert panel delivered a favorable vote on a cancer drug made by GlaxoSmithKline.

March 16, 2012
Amerigen joins Bystolic patent challenge

Another generic drug maker has joined efforts to challenge the patent on a drug made by Forest Labs for treating hypertension.

March 16, 2012
Patients taking oral cancer drugs may risk drug interactions, study finds

Pills for treating cancer have created numerous alternatives to spending hours in a clinic or at home receiving chemotherapy infusions, but risks of drug interactions remain, according to a new survey by the research arm of pharmacy benefit manager Medco Health Solutions.

March 15, 2012
Late-stage trial of MS drug shows positive results

A drug under investigation by Teva Pharmaceutical Industries and Active Biotech reduced symptoms and progression of disease in patients with multiple sclerosis, according to results of a late-stage clinical trial.

March 14, 2012
Endo seeks tougher standards for generic versions of Lidoderm

Endo Pharmaceuticals is hoping the Food and Drug Administration will back tougher regulatory approval requirements for generic versions of one of its drugs.

March 14, 2012
Forest files suit over generic versions of hypertension drug

Forest Labs has filed suit against Glenmark Generics and several other companies, alleging that they infringed on its patent for a drug to treat hypertension by seeking regulatory approval for generic versions.

March 12, 2012
Watson starts phase-3 trial of Esmya

Drug maker Watson Pharmaceuticals has started a late-stage trial of a drug made to treat benign tumors of the uterus, the company said Monday.

March 7, 2012
FDA turns down Eisai drug application

The Food and Drug Administration has declined to approve a drug made by Eisai for leukemia in certain elderly patients, the drug maker said.

March 7, 2012
Forest, Pierre Fabre drug 'significantly' reduced depression symptoms

A drug under development by Forest Labs and Pierre Fabre "significantly" reduced symptoms of major depressive disorder, the companies said Wednesday.

March 6, 2012
Takeda unit starts trial of lymphoma drug

Takeda Pharmaceutical's cancer drug unit has started a late-stage clinical trial of a drug for treating a rare form of lymphoma, the company said.

March 5, 2012
Study finds Teva allergy drug safe, effective

A drug under development by Teva Pharmaceutical Industries appears safe and effective in treating allergies, according to results of a late-stage clinical trial released Monday.

March 1, 2012
FDA approves two new drugs for pancreatic disorders

The Food and Drug Administration has approved two new drugs for pancreatic disorders, the agency said Thursday.

February 29, 2012
CVS Caremark's Accordant Health Services to collaborate with Michael J. Fox Foundation

Accordant Health Services, a CVS Caremark company, and the Michael J. Fox Foundation for Parkinson's Research on Wednesday announced a collaboration to provide to patients with Parkinson's disease who are enrolled in Accordant-sponsored care management programs information about resources available through the foundation.

February 28, 2012
FDA grants priority review to J&J heart drug

The Food and Drug Administration has given priority review to a regulatory application from Johnson & Johnson for a drug designed to reduce the risk of complications from internal blood clots.

© 2013 Drug Store News. All Rights Reserved.